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http://dx.doi.org/10.1016/j.ajic.2014.12.027Objective: To describe epidemiologic features and identify risk factors for methicillin-resistant
Staphylococcus aureus (MRSA) acquisition in a level III neonatal intensive care unit (NICU).
Setting: A prospective, cohort study in a university-afﬁliated NICU with an infection control program
including weekly nasal cultures of all neonates.
Methods: Demographic, clinical, and microbiologic data were prospectively collected between June 2009
and June 2013. Molecular characterization of MRSA isolates was done by multilocus variable number
tandem repeat ﬁngerprinting, staphylococcal cassette chromosome mec typing, and on representative
isolates by multilocus sequence typing and spa typing.
Results: Of 949 neonates, 217 (22.87%) had a culture growing MRSA, including 117 neonates testing
positive at their ﬁrst sampling. Of these latter infants, 96 (82.05%) were inborn and 59 (50.43%) had been
transferred from the nursery. Length of stay and colonization pressure were strong independent pre-
dictors of MRSA acquisition. Among MRSA isolates, 7 sequence types were identiﬁed, with ST22-IVa, spa
type t223, being the predominant strain.
Conclusions: In an endemic area, early MRSA acquisition and high colonization pressure, likely related to
an inﬂux of colonized infants from a well-infant nursery, can support persistence of MRSA in NICUs.
Surveillance, molecular tracking of strains, and reinforcement of infection control practices, involving
well-infant nurseries in a comprehensive infection control program, could be helpful in containing MRSA
transmission.
Copyright  2015 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. All rights reserved.Methicillin-resistant Staphylococcus aureus (MRSA) is a major
etiologic agent of infection worldwide.1 In the years 2009-2012 the
percentage of invasive isolates resistant to methicillin in the
European Union/European Economic Area has shown a decreasing
global trend.2 However, in 2012 the mean MRSA percentage
remained as high as 18% and above 25% in 7 countries, mainly in
eastern and southern Europe, including Italy.2
In adult patients, MRSA infections are becoming less common,
whereas infections in neonatal intensive care units (NICUs) seem toMD, Department of Sciences
ssandro,” Via del Vespro 133,
ammina).
tion for Professionals in Infectionbe becoming more frequent.3 Aggressive measures can be neces-
sary to contain the outbreaks, frequently in the form of bundle
strategies.4 However, in highly endemic areas, despite these mea-
sures being rigorously enforced, ongoing MRSA transmission and
infection have been recorded for many years.5
Colonized neonates play a major role as endogenous reservoirs
of MRSA in NICU settings.3 Consequently, active surveillance cul-
ture (ASC) programs can be instituted to identify colonized patients
and obtain otherwise unavailable information helpful to control
MRSA transmission.3,4
We recently reported the epidemiologic characteristics and the
temporal trend of the endemic MRSA colonization in the level III
NICU of the Azienda Ospedaliera Universitaria Policlinico (AOUP)
“P. Giaccone,” Palermo, Italy, during the period June 2009-June
2012.6 The purpose of our study was to describe risk factors forControl and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
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June 2013. We analyzed also antimicrobial resistance proﬁles and
molecular genetic characteristics of the MRSA isolates.
METHODS
Study design and setting
We performed a prospective cohort study of MRSA colonization
in the level III NICU of the AOUP “P. Giaccone,” Palermo, Italy. This
NICU annually admits about 250 infants. Because it is associated
with the regional reference center for genetic diseases and a
neonatal surgery unit, the NICU has a high prevalence of neonates
with malformation or complex conditions requiring surgical care
(w40%) as well as admissions from other hospitals (w35%). The
NICU has 1 intensive care room consisting of 8 cot spaces and 1
intermediate care room with 8 additional cot spaces. The average
number of nurses by working shift in the intensive and interme-
diate care rooms is 2.7 and 2.0 year-round and 2.0 and 1.5 during
the summer vacation period. The NICU is open to parents for 2
hours in the morning and 4 hours in the afternoon to allow them to
be trained in the general care of their infants. A well-infant nursery
is located in the same hospital facility where rooming-in care is
routinely performed and early breastfeeding is strongly supported.
Ampicillin-sulbactam and gentamicin are the most frequently used
antibiotics in the NICU setting.
Inclusion criteria were admission to our NICU between June 16,
2009, and June 15, 2013; hospitalization for at least 48 hours; and
collection of at least 1 nasal swab. Colonization was deﬁned as
isolation of MRSA from anterior nares without evidence of infec-
tion. Infection was deﬁned using the Centers for Disease Control
and Prevention National Healthcare Safety Network criteria for
postnatally acquired infections.7
Demographic characteristics, gestational age, birth weight,
inborn or outborn condition, delivery type, Apgar score, and co-
morbid conditions were recorded at admission. Any prior stay in
the nursery was also traced. Clinical and microbiologic data were
prospectively collected as qualitative and quantitative data,
including the following at-risk exposures: presence of central
vascular access devices, endotracheal intubation, nasal continuous
positive airway pressure, type of feeding (ie, parenteral nutrition,
gavage, breast milk, and formula), surgery, antibacterial drug
therapy, length of stay (LOS), and survival status at discharge.
Diagnosis related group weight was also included.
The study protocol was approved by the ethics committee of the
AOUP “P. Giaccone,” Palermo, Italy, and informed consent was
sought from the parents or guardians of the neonates.
Infection control strategies
Since June 2009, an ASC program has been in place, including
nasal swabs obtained on a weekly basis from all infants staying in
the NICU. Measures taken to control MRSA spread in NICU
include contact precautions, use of dedicated equipment, cyclic
training sessions of health care workers (HCWs), and intensiﬁed
environmental sanitation. Attention is paid to prevent over-
crowding and relative understafﬁng, minimize hospital LOS, and
promote safe use of invasive devices. All infants with MRSA
colonization or infection are placed in contact isolation and
cohorted, but a dedicated nursing team cannot be guaranteed
due to stafﬁng shortages. Routine cleaning policies include
postdischarge cot terminal cleaning in the NICU disinfection
room, irrespective of the MRSA carriage status of the occupant.
Environmental surfaces are not routinely cultured. No neonates
are treated with mupirocin for decolonization. Other measureselsewhere described to control MRSA outbreaks, such as chlor-
hexidine baths or unit closure, have not been carried out.
Active surveillance cultures
Surveillance specimens from the anterior nares of neonates
were incubated overnight in brain-heart infusion broth (Oxoid,
Basingstoke, UK) and then plated onto mannitol salt agar (Oxoid).
Presumptive S aureus isolates were identiﬁed according to standard
methods. MRSA isolates were searched for by colony screening onto
oxacillin agar (Mueller-Hinton with oxacillin 6 mg/L) and
conﬁrmed by the cefoxitin disk diffusion test and polymerase chain
reaction (PCR) for detection of mecA.8
The ﬁrst isolate from each patient was submitted to antibiotic
susceptibility test and genotyping. Susceptibility testing was
routinely performed using the disk diffusion method using S aureus
ATCC 25923 as the quality control strain. Macrolide-lincosamide-
streptogramin B-inducible phenotypes were detected by the D-
zone test per European Committee on Antimicrobial Susceptibility
Testing guidelines (www.eucast.org/clinical_breakpoints/). Sus-
ceptibility testing results were interpreted based on European
Committee on Antimicrobial Susceptibility Testing clinical
breakpoints.
Molecular typing of MRSA isolates
Staphylococcal cassette chromosome mec was typed by a pre-
viously described multiplex PCR method.9 Genotyping of the MRSA
isolates was routinely performed by multilocus variable number
tandem repeat ﬁngerprinting (MLVF).10 Banding patterns were
analyzed both visually and by using Bionumerics version 5.10
(Applied Maths, Sint-Martens-Latem, Belgium). Moreover, the
presence of lukS/lukF-PV and tst1 genes encoding the Panton Val-
entine leukocidine and the toxic shock syndrome toxin 1, respec-
tively, was tested for by PCR.11 The ST22-MRSA-IVa isolates were
also tested by PCR for the carriage of enterotoxins C and L (ie, sec,
sel) using previously described primers and conditions.11
A subset of representative isolates, including all the different
MLVF patterns, was analyzed by multilocus sequence typing
(MLST). MLST allelic proﬁles and sequence types were assigned by
submission to the S aureus MLST database (www.mlst.net). Addi-
tionally, spa typing was carried out on representative MRSA iso-
lates.12 The spa type was determined using Ridom StaphType
software (http://www.ridom.de/staphtype/).
Statistical analysis
Statistical analysis was performed by using EpiInfo (version 7;
Centers for Disease Control and Prevention, Atlanta, Ga) and R
software, version 2.13.0 (R Foundation for Statistical Computing,
Vienna, Austria). Time intervals at risk for MRSA colonization were
deﬁned as the time between admission and date of ﬁrst nasal swab
positive for MRSA colonization in patients testing negative to the
ﬁrst nasal swab, and time between admission and death or
discharge for noncolonized infants. Patients testing positive were
considered to be MRSA colonized from the date of their ﬁrst posi-
tive sampling until discharge or death. Overcrowding was assessed
by calculating the average bed occupancy rate (ie, the percentage of
occupied beds per day divided by the number of available beds)
during the at-risk stay of each patient. The infant-to-nurse ratio
during the at-risk stay of each patient was calculated by using the
daily census divided by the number of nurses on duty. Colonization
pressure was calculated as the proportion of total patient-days that
were MRSA-positive patient-days during the time at risk. All
colonized patients contributed to colonization pressure.
Table 1
General characteristics of patients at admission to the neonatal intensive care
unit (June 2009-June 2013, Palermo, Italy)
Variable Result
Total 949 (100)
Gender
Male 547 (57.64)
Age at admission, h
<24 728 (76.61)
24-48 114 (12.01)
>48 105 (11.06)
Gestational age, wk
<30 43 (4.53)
30-36 312 (32.88)
>36 588 (61.96)
Patient transferred from nursery 225 (23.71)
Birth weight, g
1,000 28 (2.95)
1,001-1,500 53 (5.58)
1,501-2,000 112 (11.80)
2,001-2,500 171 (18.02)
>2,500 580 (61.12)
Inborn 595 (62.70)
Twin birth 123 (12.96)
Cesarean delivery 623 (65.65)
Apgar score at 5 min < 8 97 (10.22)
Malformation 173 (18.23)
NOTE. Values are presented as n (%).
Table 2
Characteristics of patients in the neonatal intensive care unit stratiﬁed by
methicillin-resistant Staphylococcus aureus (MRSA) colonization status at their
ﬁrst nasal swab (June 2009-June 2013, Palermo, Italy)
Variable
First nasal swab
P valueMRSA negative MRSA positive
Total 832 (87.67) 117 (12.33)
Gender
Male 484 (58.17) 63 (53.85) .37
Age at admission, h
<24 628 (75.48) 100 (85.47) .059
24-48 106 (12.74) 8 (6.84)
>48 96 (11.54) 9 (7.69)
Gestational age, wk
<30 42 (5.05) 1 (0.85) .008
30-36 283 (34.01) 29 (24.79)
>36 666 (80.05) 86 (73.50)
Patient transferred from
nursery
166 (19.95) 59 (50.43) <.001
Birth weight, g
1,000 28 (3.37) 0 (0) .008
1,001-1,500 51 (6.13) 2 (1.71)
1,501-2,000 99 (11.90) 13 (11.11)
2,001-2,500 150 (18.03) 21 (17.95)
>2,500 500 (60.10) 80 (68.38)
Inborn 499 (59.98) 96 (82.05) <.001
Twin birth 111 (13.34) 12 (10.26) .34
Cesarean delivery 549 (65.99) 74 (63.25) .53
APGAR score at 5 min < 8 92 (11.06) 5 (4.27) .02
Malformation 158 (18.99) 15 (12.82) .09
NOTE. Values are presented as n (%).
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compared by using Pearson c2 test, c2 test for linear trend, or Fisher
exact test, as appropriate. Continuous variables were reported as
mean  SD and compared by using Student t tests when normally
distributed, otherwise theywere presented asmedian (interquartile
range) and analyzed by using the Mann-Whitney-Wilcoxon test.
All variables that were found to be signiﬁcantly associated
(P < .05) with acquiring MRSA colonization in the univariate anal-
ysis were included in a backward stepwise multivariable logistic
regression analysis. The model with the lowest Akaike information
criterion was considered to have the best ﬁt and the Hosmer-
Lemeshow goodness of ﬁt was used to determine how well the
ﬁnal model ﬁt the data. Adjusted odds ratios and 95% conﬁdence
intervals were calculated for the variables retained in the best-
ﬁtting models. All reported P values were 2-sided and P < .05 was
considered signiﬁcant.
RESULTS
General epidemiologic features of nasal colonization with MRSA
During the study period, 999 infants were admitted to the NICU,
of whom 949 fulﬁlled the criteria for inclusion in the study. There
were no signiﬁcant differences in the number of enrolled infants
among the 4 years of study.
As shown in Table 1, of the 949 patients, 354 (37.30%) were
outborn and 173 (18.23%) had malformation. Moreover, 225
(23.71%) neonates had been admitted to the nursery before being
transferred to the NICU.Median LOS in the NICUwas 11 days (range,
2-178 days). The main characteristics of the 949 infants at admis-
sion are summarized in Table 1.
During the 4-year period, 2,549 nasal swabs were cultured
(mean, 2.69 per patient). The ﬁrst nasal swab was obtained on
average 3.91 days after admission (4 [1-6] days). Overall 217 neo-
nates (22.87%) had a nasal surveillance culture growing MRSA. Of
these, 117 (53.92%) tested positive at the time of their ﬁrst sam-
pling, whereas the remaining 100 (46.08%) acquired MRSA later
during their NICU stay. The interval of time between admission and
collection of the ﬁrst nasal swab from the NICU infants did not
differ signiﬁcantly between the 2 subgroups (4 [2-6] days for those
with the ﬁrst swab positive vs 3 [1.5-6.5] days for those with the
ﬁrst swab negative; P ¼ .10).
Table 2 shows the differential characteristics of the 2 subgroups
of patientsdMRSA colonized and noncolonizeddat their ﬁrst nasal
sampling, at the NICU admission. A signiﬁcantly higher proportion
of infants being inborn and coming from the nursery was found
among the patients testing positive at their ﬁrst nasal swab
compared with those who did not.
Incidence and risk factors for MRSA acquisition
The mean quarterly incidence density was 6.84 cases per 1,000
patient-days (95% conﬁdence interval, 5.62-8.31). The median
(interquartile range) quarterly colonization pressure was 15.34%
(5.44%-27.44%). Figure 1 shows that during the study period an
overall decreasing trend was evident with colonization incidence
density approximately halving; that is, from 14.86 to 7.86 cases per
1,000 patient-days. This trend was interrupted by a transient in-
crease during the ﬁfth quarter and by a subsequent major peak of
incidence/colonization pressure, involving the eighth to 10th
quarters. As previously reported, the import in the NICU of a MRSA
strain ST1-IVa followed by a period of substantial overcrowding
were the probable driving factors.6 The declining trend came again
to a halt in the 14th quarter concurrently with the emergence in the
NICU of a strain of Klebsiella pneumoniae carbapenemase-producing K pneumoniae (KPC-Kp).13 Indeed, between September
18, 2012, and November 14, 2012, KPC-Kp was recovered from 10
neonates. The sudden requirement for a prioritized cohorting of the
patients colonized with KPC-Kp placed a major burden on the
nursing staff and made it necessary to convert the separate inter-
mediate care room into a KPC-Kp cohort room, while cohorting of
patients positive for MRSA infection was forcedly restricted.13
A seasonal variation was evident for MRSA colonization with
incidence density peaking in the summer and autumn quarters
(June-November).
Fig 1. Distribution of incidence density of methicillin-resistant Staphylococcus aureus
(MRSA) acquisition and MRSA colonization pressure rates by quarter during the study
period.
Table 3
Factors associated with acquisition of methicillin-resistant Staphylococcus aureus
(MRSA) in patients testing negative at the ﬁrst nasal swab, June 2009-June 2013,
Palermo, Italy
Variable
Infants who
acquired
MRSA No.
100 (12.02%)
Infants who
did not acquire
MRSA No.
732 (87.98%) P value
At hospital admission
Male gender 42 (42.0) 442 (60.38) <.001
Twin birth 22 (22.0) 89 (12.16) .005
Malformation 30 (30.0) 128 (17.49) .003
Inborn 65 (65.0) 434 (59.29) .27
Birth through cesarean
section
80 (80.0) 469 (64.07) .003
Admission to neonatal
intensive care unit
< 24 h after birth
83 (83.0) 545 (74.45) .07
Apgar score at 5 min <8 18 (18.0) 74 (10.11) .03
Gestational age, wk 35.5 (32-38) 37 (35-39) <.001
Birth weight, g 2,170 (1,420-2,770) 2,775 (2,190-3,265) <.001
Patient transferred
from nursery
16 (16.0) 150 (20.49) .29
During hospital stay
Central venous access
device
No 49 (49.0) 472 (64.5) <.001
Yes, 1-14 d 23 (23.0) 171 (23.4)
Yes, >14 d 28 (28.0) 87 (11.9)
Endotracheal tube
No 61 (61.0) 582 (79.5) <.001
Yes, 1-3 d 16 (16.0) 51 (7.0)
Yes, >3 d 23 (23.0) 98 (13.4)
Nasogastric tube
No 38 (38.0) 462 (63.1) <.001
Yes, 1-14 d 18 (18.0) 159 (21.7)
Yes, > 14 d 43 (43.0) 107 (14.6)
Nasal continuous positive
airway pressure
No 58 (58.0) 599 (81.8) <.001
Yes, 1-3 d 14 (14.0) 71 (9.7)
Yes, > 3 d 28 (28.0) 61 (8.3)
Parenteral nutrition 72 (72.0) 472 (64.48) .14
Surgical procedure 14 (14.0) 69 (9.43) .13
Systemic antibacterial
therapy
No 36 (36.0) 297 (40.57) .001
Yes, 1-7 d 15 (15.0) 213 (29.10)
Yes, > 7 d 49 (49.0) 220 (30.05)
Formula feeding 98 (98.0) 683 (93.31) .13
Breast milk feeding 57 (57.0) 383 (52.32) .95
Diagnosis-related group
weight
1.58 (0.70-5.6) 0.76 (0.72-3.25) .0065
Length of stay, d 15.0 (9-26) 10 (7-19) <.001
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whose ﬁrst nasal swab was negative (Table 3). No statistically sig-
niﬁcant difference was found between the infants who acquired
MRSA and those who did not when comparing the proportion of
patients who were inborn or transferred to the NICU from the
nursery. The median LOS as well as the mean of percent coloniza-
tion pressure were both signiﬁcantly higher for colonized infants.
Conversely, the difference between these 2 subgroups was not
statistically signiﬁcant for daily occupation rate and infant-to-nurse
ratio.
In accordance with the results of the multiple logistic regression
analysis (Table 4), MRSA acquisitionwas negatively associated with
male gender, an increasing birth weight, and systemic antibacterial
therapy. Conversely, LOS and colonization pressure were conﬁrmed
to be strong independent risk factors for MRSA acquisition: indeed,
for every day and percent unit of increment, the odds ratio of
becoming colonized with MRSA increased by 4% and 5%,
respectively.
Twenty-eight of 100 infants (28.0%) who acquired MRSA during
their NICU stay developed late-onset sepsis compared with 59 out
of 732 (8.06%) who did not (P < .001). A total of 23 infants (2.81%)
died during their NICU stay, but in-hospital mortality rate was not
signiﬁcantly different between the 2 subgroups of patients (2.17%
vs 2.89%; P ¼ .69).Daily bed occupancy
rate %
81.2 (68.7-87.5) 75 (62.5-81.2) .61
Infant-to-nurse ratio 3.4 (2.6-3.8) 3.1 (2.2-3.7) .63
Colonization pressure % 18 (9.5-26) 12 (8-19) <.001
NOTE. Data are presented as n (%) or median (interquartile range).Characteristics of the MRSA isolates
Two hundred seventeen isolates from 216 patients were avail-
able for typing. One infant only was shown to simultaneously carry
2 different strains (ST22-IVa and ST1-IVa). Overall, 7 sequence
types (STs) were identiﬁed (ST1, ST7, ST8, ST20, ST22, ST45, and
ST97) with ST22-IVa being the predominant (190 out of 217;
87.56%). SCCmec type IVa was identiﬁed in all MRSA isolates. ST22-
IVa isolates were further subdivided by MLVF into 9 different
subtypes, of which only the subtype ST22-A was detected through
the entire period of the study. The second most common ST was
ST1, which was detected in 20 isolates. ST1 was responsible for 2
epidemic spreads, of which the ﬁrst was initiated by the import of
an outborn infected patient, involved 15 infants, and made neces-
sary a strengthening of the infection control practices to interrupt
transmission.14 They were assigned with type t127 by spa typing.
TheMRSA isolates were fully susceptible or resistant to a limited
number of non-b-lactam antibiotics. Only the ST1-IVa isolates
showed an inducible clindamycin-resistant phenotype. No isolatewas found to carry the Panton Valentine leukocidine gene
sequence. The tst1, sec, and sel gene sequences were detected in all
ST22-MRSA-IVa isolates. These isolates were assigned to type t223
by spa typing.DISCUSSION
We investigated the epidemiologic pattern of MRSA coloniza-
tion in a level III university-afﬁliated NICU where an endemic
presence of a strain characterized as tst1 positive, UK-EMRSA-15/
“Middle Eastern Variant” had been previously documented.6
High incidence density and colonization pressure characterized
our NICU setting through the 4-year study period. After the
Table 4
Best ﬁtting logistic regression model, by Akaike information criterion, for predicting
the risk of colonization with methicillin-resistant Staphylococcus aureus
(Hosmer-Lemeshow goodness-of-ﬁt test P ¼ .21)
Variable
Adjusted odds ratio
(95% conﬁdence interval) P value
Gender, male vs female 0.60 (0.37-0.97) .038
Birth weight, per 100 g increase 0.96 (0.93-0.99) .047
Malformation, yes vs no 1.77 (0.98-3.19) .062
Systemic antibacterial therapy,
per day increase
0.97 (0.95-0.99) .026
Length of stay, per day increase 1.04 (1.02-1.05) <.001
Colonization pressure %,
per unit increase
1.05 (1.02-1.07) <.001
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downward trend was registered.
Screening at admission was not performed. However, a propor-
tion of colonized infants as high as 53.92% was shown to be positive
at their ﬁrst nasal swab, the majority being inborn. This ﬁnding is
unexpectedbased on the available literature. A recentmeta-analysis
shows, indeed, a signiﬁcantly higher colonization rate among out-
born infants, a plausible consequence of their older age and more
prolonged exposure to the health care setting.3 In addition, about
50% of infants testing positive at their ﬁrst nasal swab had been
transferred from the nursery. MRSA transmission is already known
to be highly efﬁcient in nurseries due to the routine care practices
and a lower awareness by HCWs of general infection control mea-
sures.15 Unfortunately, our ASC program was not extended to the
nursery, preventing us from drawing deﬁnitive conclusions.
In accordancewith previous observations, a seasonality of MRSA
colonization was apparent in our setting. This phenomenon has
been reported in a signiﬁcant proportion of studies about MRSA
infection, particularly as an association of warmer seasons with
skin and soft-tissue infections.16 Higher incidences in the summer
and autumn have been speciﬁcally observed for community-
associated MRSA.16 Comparatively few investigations have
focused on nasal colonization, with nondeﬁnitive conclusions.16
MRSA seasonality deserves to be thoroughly studied. Actually,
seasonality could be the epiphenomenon of many concurrent,
speciﬁc variables, such as overcrowding and understafﬁng (eg,
stafﬁng shortage during summer holidays) along with pressure by
MRSA carriage in the community in highly endemic areas, such as
the southern European countries.16
In our setting colonization pressure was shown to be a powerful
risk factor, odds of acquiring MRSA being 5% higher per unit in-
crease. Conversely, overcrowding and understafﬁng did not play a
key role in promoting MRSA acquisition. Previous reports have
repeatedly emphasized the role of a high colonization pressure,
which has been shown to be able to supersede the effects of other
transmission variables, including infection control measures.17,18
Moreover, it is widely acknowledged that once colonization pres-
sure is high, it becomes the major variable affecting MRSA
acquisition.17,18
A growing role of community-associated MRSA strains is re-
ported in NICUs.6,19,20 However, a meaningful distinction between
health-care associated MRSA and community-acquired MRSA
strains is increasingly challenging and MRSA strains previously
identiﬁed as belonging to either group are reported to circulate in
both community and health care settings.14,21 Moreover, highly
endemic community settings are likely to promote spilling of MRSA
into the NICUs via HCWs or parents.
The endemic strain detected in our NICU was the tst1 positive,
UK-EMRSA-15/“Middle Eastern Variant,” which was ﬁrst described
by Biber et al22 as genetically related to the epidemic EMRSA-15
clone. Like in Gaza, in our geographic area a question arises aboutthe origin of this clone; that is, a health care-associated MRSA
escaping toward the community or, alternatively, an ST22-MSSA
that has evolved into a community-acquired MRSA clone. The
detection in healthy children in the community of this MRSA strain
and of an ST22-MSSA-spa-t223 strain (unpublished data) appears
to be more supportive of this latter hypothesis.23 Other strains
entered the NICU in a sporadic or epidemic way during the study
period, all with characteristics of community-acquired MRSA
strains. In particular, ST1-MRSA-IVa isolate spa type t127 was
detected as responsible for 2 different events.14 This MRSA lineage
is considered to have a high zoonotic potential and has been
recently reported in Italy, mainly from fattening pigs.24
As found by other investigators, in NICUswith a high endemicity
and multiple circulating MRSA strains, the objective to deﬁnitively
eradicate MRSA from the NICU can be unrealistic.5,25
With a 4-year period of prospective epidemiologic and labora-
tory surveillance and molecular typing of MRSA isolates, our study
provides signiﬁcant data about risk factors for acquisition and
evolution of MRSA clones in a level III NICU. Molecular typing is
critical to support effective surveillance and control strategies.
MLVF, in particular, has been shown to be a very useful, high-
throughput, and cheap tool to rapidly discriminate the MRSA iso-
lates and timely detect endemic, epidemic, and unrelated strains.
Nonetheless, our study has many limitations. Screening at
admission to our NICU was not made, which prevented us from
more accurately detecting time and place of MRSA acquisition and
deﬁning the role of the well-baby nursery and of outborn admis-
sions. Moreover, in accordance with the objective of our study,
infants staying in the nursery did not undergo nasal sampling.
Neither HCWs nor family members were screened for MRSA, which
could have resulted in unidentiﬁed entry or transmission routes.
However, the optimal approach of active surveillance testing to
detect MRSA carriage screening among HCWs has not been deﬁn-
itively agreed upon and active surveillance is only recommended
for implementation in response to clusters of colonization or
infection cases with a suspected epidemiologic link to an HCW.4,26
Likewise, the role of parents in importing MRSA into NICU settings
requires further study. Moreover, the presence of possible envi-
ronmental reservoirs has not been explored due to conﬂicting ev-
idence about the contribution of persistent environmental MRSA
contamination in health care settings.26 Extranasal sites were not
considered in the ASC program because nasal cultures only are
widely agreed to be sufﬁciently sensitive.3,4 Moreover, molecular
testing by PCR was not adopted due to the inconclusive evidence
about its cost-effectiveness when measured by the MRSA acquisi-
tion rate26 and the need to maintain the standard culture-based
approach for the purpose of typing the MRSA isolates. A correla-
tion between colonization and sepsis by MRSA was not attempted
because of the low yield of blood cultures in neonates.27 Finally,
because this was an observational study conducted in a single NICU
in an university-afﬁliated hospital, the results may not be
generalizable.
CONCLUSIONS
Our study results suggests that in a hyperendemic area early
MRSA acquisition and high colonization pressure, likely related to a
constant inﬂux of colonized infants from a well-infant nursery, can
support persistence of MRSA in NICU settings and substantially
interfere with infection control strategies. Our ﬁndings highlight
also some further concerning features of epidemiology of MRSA in
NICU settings, such as the recurrent emergence of sporadic or
clustered MRSA strains occurring amidst a background of an
endemic MRSA strain. Careful vigilance with surveillance, molec-
ular tracking of strains, and the reinforcement of infection control
M. Giuffrè et al. / American Journal of Infection Control 43 (2015) 476-81 481practices involving well-infant nurseries in a comprehensive
infection control program could be helpful in containing MRSA.
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